Skip to main content

Live· 357 releases in the last 30 days

Oncology announcements, as they publish.

Trial results, regulatory decisions, diagnostic launches, research grants and treatment-centre news. Oncology is the most-announced field in medicine and the releases arrive from companies, hospitals and universities alike.

Latest on this wire

TimeHeadline
Aug 03Florida Cancer Specialists & Research Institute Welcomes Nagapratap Ganta, MD and Aryanna Jordan, MD to Statewide Practice
PR Newswire (US) — Real Estate · US
Aug 03Fresenius Kabi Expands Oncology and Immunology Offering Through FDA-Approved Rituximab Biosimilar
EuropaWire (EU) · US
Aug 03Tennessee Oncology Opens New State-of-the-Art Tullahoma Medical Center
PR Newswire (US) — Real Estate · US
Aug 03Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform
Newswire.com
Aug 03Canon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer Screening
GlobeNewswire — Public Companies · US
Aug 03Cizzle Bio Expands Access to Early Lung Cancer Detection Through Strategic Laboratory Collaboration with BioBridge Global in South Texas
PR Newswire (US) — Health · US
Aug 03The Oncology Institute Rebrands as Starling Oncology
GlobeNewswire — Public Companies · US
Aug 03Stand Up To Cancer Adds New Scientific Advisory Committee Members
PR Newswire (US) — Consumer Technology · US
Aug 03Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
PR Newswire (Brazil) · US
Aug 03Author Annod Noremac’s New Book, "Going Crazy," Centers Around a Young Woman Who Uncovers Family Secrets Following a Devastating Diagnosis of Colon Cancer
PR.com (US) · US
Aug 03Invenio Imaging Announces Completion of Enrollment in Landmark Study of AI-Based Image Analysis for Lung Cancer
PR Newswire (Canada) — All Releases · US
Aug 03Zepzelca® (lurbinectedin) in combination with atezolizumab approved as first-line maintenance therapy for extensive-stage small cell lung cancer in Qatar
Cision News · SE

Releases are matched on the headline, deduplicated, and exclude securities-litigation solicitations. Each links to the publisher's original.

You are seeing 12 of 357.

The other 345 crossed the wire in the last 30 days on this topic alone — most of them never reached a news site. A release is only useful before everyone else has it, and this page is a day behind by design.

Watch this topic live →

Free to start. No card. Cancel in one click.

What to watch for

Conference timing shapes this wire — a cluster of readouts days before a major oncology meeting is scheduling, not coincidence.

Frequently asked questions

Is this only drug companies?
No. Hospitals, research institutes, charities and diagnostics firms publish here too, and their releases are the least covered.
How current is the page?
It refreshes hourly and lists the newest matching releases first.

Monitoring oncology on the wire

Why the wire beats the news

By the time a story is written, the release it came from has been public for hours — and the ones nobody wrote about are never seen at all. Most of what crosses this topic is the second kind: a regulator's notice, a mid-size company's filing, a ministry statement in a language the wires do not translate. That is where the stories nobody else has come from.

How current this page is

This page refreshes hourly and shows the twelve most recent matching releases. The live feed updates continuously and reaches the whole archive, and alerts fire the moment a new release matches.

Other topics